Cardiac myocytes are known to express the high-capacity inducible isoform of nitric oxide (NO) synthase (iNOS). Since tetrahydrobiopterin (BH4) is an essential cofactor for NO formation, we investigated whether BH4 synthesis is required for cytokine-induced NO production in cultutred rat cardiac myocytes . The total biopterin content of untreated cardiac myocytes was below our limit of detection. However, treatment with inter-leukin-lcx. and interferon-y (IL-l j IFN) caused a significant rise in biopterin levels and induced NO synthesis. iNOS mRNA and GTP cyclohydrolase I ( GTPCH ) mRNA were induced by IL-l j IFN in parallel. 2,4-Diamino-6-hydroxypyridine (DAHP), a selective inhibitor of GTPCH, inhibited both the increase in cellular levels of BH4 as well as the concomitant formation of NO caused by IL-l j IFN . This inhibition by DAHP was reversed by coaddition of sepiapterin which is a substrate for BH4 synthesis. Thus BH4 synthesis is an absolute requirement for induction of NO synthesis by cytokines in cardiac myocytes.
Introduction
The nitric oxide (NO) signaling pathway is thought to playa direct role in regulating the contractile properties of cardiac muscle both in vitro and in vivo (1) (2) (3) . The inducible isoform of NO synthase (iNOS) mediates a sustained increase in NO production in response to cytokines in the cardiac myocytes; however, the regulation of NO synthesis in these cells remains poorly understood. § Author to whom correspondence should be addressed. * Parts of the work have been presented at the 4th
Meeting of Cytokine and Neopterin held on July 19, 1997, in Tokyo, Japan.
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Tetrahydrobiopterin (BH4) is an essential cofactor for NO formation. The synthesis of BH4 occurs via two distinct pathways: a de novo synthetic pathway which uses guanosine triphosphate (GTP) as a precursor, and a salvage pathway using pre-existing dihydropterins (4) . GTP cyclohydrolase I ( GTPCH), the first and rate-limiting enzyme in the de novo synthesis of BH 4 , causes the formation of dihydroneopterin triphosphate from GTP. Subsequently, dihydroneopterin triphosphate is metabolized to BH4 by 6-pyruvoyltetrahydropterin synthase and sepiapterin reductase with the concomitant formation of tetrahydropterin intermediates . The present investigation addressed the role of BH4 synthesis in immuno-stimulant-activated cardiac myocytes.
Materials and Methods

Cell culture
Primary cultures of rat neonatal cardiac myocytes were prepared as previously described ( 5).
Nitrite production
Nitrite, an indicator of NO synthesis, in the medium of cardiac myocytes was measured by Griess assay as previously described (6) .
Biopterin assay
Cellular biopterin (biopterin plus BH2 and BH 4 ) was measured after acidic oxidation of the reduced forms of biopterin with iodine as previously described (6) . The amount of biopterin was analyzed by HPLC according to the method of Fukushima and Nixon (7).
Measurement of mRNA levels for WOS and GTPCH by RT-PCR
RT -PCR was preformed by standard methods as described previously (8) . PCR products were separated by electrophoresis on a 1.5% agarose gel containing ethidium bromide and visualized by ultraviolet light-induced fluorescence. The intensity of the PCR bands on the negative film of the gel photographs was quantified by use of a video densitometer linked to a computer analysis system (ACT, Kanagawa, Japan) .
Results and Discussion
Interleukin -1 a (IL-l ) activates rat cardiac myocytes (RCMC) to synthesize and release nitrite. Nitrite accumulation in cell culture medium increased as a function of TL-l concentration and the duration of IL-l exposure . As shown in Fig. lA, IL-l-induced nitrite release was markedly potentiated by interferon-y ( IFN). In contrast, RCMC treated with IFN alone did not produce detectable levels of nitrite. Similarly, tumor necrosis factor-a (TNF) dose-dependently increased nitrite synthesis in the presence of IFN, but TNF alone has little effect on nitrite production by RCMC ( I.
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• .a not N "'-nitro-D-arginine (D-NNA), elicited concentration-dependent inhibition of IL-I/IFN-induced nitrite synthesis. The EC so concentrations for NMA and NNA were 30 ~M and 100 ~M, respectively (Fig. IC) . This rank order for potency is similar to that observed in lipopolysaccharide-activated rat aortic vascular smooth muscle cells (6) and characteristic of iNOS (9) .
Although there have been several reports demonstrating that rat cardiac myocytes have iNOS mRNA and activity, biopterin synthesis has not previously been investigated in these cells . Total intracellular biopterin levels (reduced and oxidized forms), undetectable under basal conditions , increased after 24 h exposure to IL-l / IFN (see inset in Fig. 2A ). To determine whether the IL-I / IFN-induced increase in cellular biopterin requires mRNA or protein synthesis, experiments were performed with actinomycin 0 and cycloheximide. Actinomycin D (0 .5 ~g/ml ) and cycloheximide ( 1 ~g/ml) both reduced the cellular biopterin to undetectable levels ( Fig. 2A) . This result suggests that the increase in cellular bioptcrin after IL-l/ IFN is due to induced production of biopterin. Dexamethasone also inhibited cellular biopterin levels by approximately 70% in IL-l / IFN-stimulated RCMC ( Fig. 2A) . To establish whether NO synthesis is affected by changes in intracellular biopterin levels, the de novo biopterin synthesis in IL-I / IFN-stimulated RCMC was decreased b y treatment of the cells with 2,4-diamino-6-hydroxypyrimidine (DAHP), a selective inhibitor of GTP cyclohydrolase. The IL-l/IFN-induced increase in cellular biopterin was completely abolished when cells were concomitantly treated with DAHP (3 mM: inset of Fig. 2B ). In addition to blocking BH4 synthesis, DAHP elicited a concentra-tion-dependent inhibition of IL-l / IFN -induced nitrite synthesis with an EC so of approximately 0.6 mM (Fig.  2B) . The influence of DAHP on the time course of nitrite production by IL-l/IFN-activated RCMC is shown in Fig. 2C . DAHP inhibited nitrite production at all time points studied. Inhibition by DAHP was completely overcome by the co-administration of sepiapterin (I 00 ~M, SEP) . This is an agent which is a substrate for BH4 synthesis via the dihydrofolate reductase-dependent ptein salvage pathway, and therefore, would be expected to restore BH4 synthesis during GTP cyclohydrolase blockade. The reversal by sepiapterin was overcome by methotrexate (MTX), an inhibitor of the pterin salvage pathway. N-acetylserotonin (NAS) has been shown to block BH4 synthesis in cells by selectively inhibiting sepiapterin reductase (an enzyme which catalyzes two consecutive NADPH-dependent keto-oxidation reactions, the final steps in BH4 synthesis from GTP). As shown in Fig. 2B , NAS at I mM abolished the IL-IjIFN-induced increase in cellular BH4. In addition, NAS elicited a concentration-dependent inhibition of IL-IjIFN-induced nitrite synthesis by RCM C with an EC so of approximately 60 mM (Fig. 2B) .
To evaluate the basis for the increase in intracellular biopterin and its relation to iNOS, we determined the abundance of mRNAs for iNOS and GTPCH in IL-ljIFN-treated RCMC by RT-PCR using specific primers for iN OS and GTPCH . Following treatment with IL-IjIFN, iN OS mRNA became detectable by 2 h, peaked at 8 h, and remained at high levels for at least 24 h. The time course for expression of GTPCH mRNA paralleled that of iNOS mRNA after treatment of IL-IjIFN (data not shown). In conclusion, cytokines induce the de novo synthesis of BH4 in cardiac myocytes and this event is essential for the induction of NO release. The induction of NO synthesis is accompanied by co-induction of iNOS and GTPCH mRNA and is antagonized by blocking BH4 synthesis. While manipulation of the NO signalling pathway in vivo has yielded conflicting results (10, 11) , induction of NOS within the myocardium might contribute to cytokine-related cardiac dysfunction in some patients. Disruption of pterin synthesis may be an important target for pharmacologic interventions intended to limit NO overproduction under such conditions.
